Mar 7, 2023 | access, health policy, oncology, oncopolicy |
Timely access to innovative treatments is crucial for those living with cancer. However, for Candians with cancer, the approval process for such treatments can be lengthy and complex. Cancer treatments usually receive Health Canada and subsequent health technology...
Feb 8, 2023 | health policy, oncology, oncopolicy |
PROVIDED BY Cancer Action Now TORONTO, Feb. 8, 2023 /CNW/ – As the Prime Minister and Premiers convened in Ottawa yesterday to discuss much-needed reforms to Canada’s health systems, cancer patients and stakeholder groups...
Nov 8, 2022 | health policy, oncopolicy |
this article was originally published on the macdonald laurier laurier institute blog by W. Neil Palmer on November 1.2022 and republished here. The Patented Medicine Prices Review Board (PMPRB) is once again attracting the ire of the life sciences industry and...
Nov 7, 2022 | access, health policy, oncology, oncopolicy |
as the ministers of health across the country meet in vancouver over the next couple of days, the CANCER ACTION NOW ALLIANCE members have drafted a letter to remind them of the canadians, who every day are diagnosed, treated, screened and die from cancer. an ongoing...
Nov 2, 2020 | oncopolicy, precision medicine |
throughout the month of november, the cancer collaborative in collaboration with the european cancer patients coalition [ECPC] will highlight the growing role that precision medicine plays in oncology through the CRACKING THE CANCER CODE campaign. the premise of...
Jan 13, 2020 | biosimilars, health policy, oncology, oncopolicy |
last december, the canadian institute for health information published statistics on drug spending, finding that in 2018 approximately 40% of drug spending was spent on 2% of beneficiaries. of this 2%, three out of five individuals used a drug therapy that cost...
